These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11343865)

  • 1. Association study of schizophrenia with polymorphisms at six candidate genes.
    Virgos C; Martorell L; Valero J; Figuera L; Civeira F; Joven J; Labad A; Vilella E
    Schizophr Res; 2001 Apr; 49(1-2):65-71. PubMed ID: 11343865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
    Gunes A; Scordo MG; Jaanson P; Dahl ML
    Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients.
    Liou YJ; Liao DL; Chen JY; Wang YC; Lin CC; Bai YM; Yu SC; Lin MW; Lai IC
    Neuromolecular Med; 2004; 5(3):243-51. PubMed ID: 15626824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family association study between DRD2 and DRD3 gene polymorphisms and schizophrenia in a Portuguese population.
    Ambrósio AM; Kennedy JL; Macciardi F; Macedo A; Valente J; Dourado A; Oliveira CR; Pato C
    Psychiatry Res; 2004 Mar; 125(3):185-91. PubMed ID: 15051179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects.
    Li T; Liu X; Zhao J; Hu X; Ball DM; Loh el-W; Sham PC; Collier DA
    Am J Med Genet; 2002 Apr; 114(3):329-35. PubMed ID: 11920858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of psychotic disorders and polymorphisms in HT2A, DRD2, DRD4, SLC6A3 (DAT1), and BDNF: a family based association study.
    Fanous AH; Neale MC; Straub RE; Webb BT; O'Neill AF; Walsh D; Kendler KS
    Am J Med Genet B Neuropsychiatr Genet; 2004 Feb; 125B(1):69-78. PubMed ID: 14755448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [D3 dopamine receptor gene Ser9Gly polymorphism in Russian patients with schizophrenia].
    Aksenova MG; Shestakova IuN; Abramova LI; Frolova LP; Shemiakina TK; Lezheĭko TV; Lavrushina OM; Barkhatova AN; Nosikov VV; Golimbet VE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(10):57-61. PubMed ID: 15553379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment.
    Lattuada E; Cavallaro R; Serretti A; Lorenzi C; Smeraldi E
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):489-93. PubMed ID: 15383158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular-genetic study of early-onset schizophrenia].
    Pakhomova SA; Korovaĭtseva GI; Monchakovskaia MIu; Vil'ianov VB; Frolova LP; Kasparov SV; Kolesnichenko EV; Golimbet VE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(2):66-9. PubMed ID: 20436453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)).
    Gelernter J; Kranzler H; Lacobelle J
    Genomics; 1998 Sep; 52(3):289-97. PubMed ID: 9790747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between schizophrenia and DRD3 or HTR2 receptor gene variants.
    Baritaki S; Rizos E; Zafiropoulos A; Soufla G; Katsafouros K; Gourvas V; Spandidos DA
    Eur J Hum Genet; 2004 Jul; 12(7):535-41. PubMed ID: 15083167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder.
    Nicolini H; Cruz C; Camarena B; Orozco B; Kennedy JL; King N; Weissbecker K; de la Fuente JR; Sidenberg D
    Mol Psychiatry; 1996 Dec; 1(6):461-5. PubMed ID: 9154247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.
    Spurlock G; Williams J; McGuffin P; Aschauer HN; Lenzinger E; Fuchs K; Sieghart WC; Meszaros K; Fathi N; Laurent C; Mallet J; Macciardi F; Pedrini S; Gill M; Hawi Z; Gibson S; Jazin EE; Yang HT; Adolfsson R; Pato CN; Dourado AM; Owen MJ
    Am J Med Genet; 1998 Feb; 81(1):24-8. PubMed ID: 9514583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genes for major psychosis: aberrant sequence or regulation?
    Petronis A
    Neuropsychopharmacology; 2000 Jul; 23(1):1-12. PubMed ID: 10869881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.
    Segman RH; Heresco-Levy U; Finkel B; Inbar R; Neeman T; Schlafman M; Dorevitch A; Yakir A; Lerner A; Goltser T; Shelevoy A; Lerer B
    Psychopharmacology (Berl); 2000 Nov; 152(4):408-13. PubMed ID: 11140333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients.
    Dahmen N; Müller MJ; Germeyer S; Rujescu D; Anghelescu I; Hiemke C; Wetzel H
    Schizophr Res; 2001 Apr; 49(1-2):223-5. PubMed ID: 11428346
    [No Abstract]   [Full Text] [Related]  

  • 20. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
    Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM
    Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.